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Abstract

Author Manuscript

The ability to accurately predict violence and other forms of serious antisocial behavior would
provide important societal benefits, and there is substantial enthusiasm for the potential predictive
accuracy of neuroimaging techniques. We review the current status of violence prediction using
actuarial and clinical methods, and assess the current state of neuroprediction. We then outline a
number of questions that need to be addressed by future studies of neuroprediction if
neuroimaging and other neuroscientific markers are to be successfully translated into public policy
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The utility of violence prediction

Author Manuscript

Each year, the United States loses nearly 3.2 trillion dollars to crime [1], with violent crime
responsible for the majority of these costs [2]. This figure includes victim-specific losses
such as opportunity costs and lost productivity, but the costs of treatment and incarceration
for offenders–which are borne by all citizens - are no less staggering. Violence (and other
forms of serious antisocial behavior) is not a normally distributed “trait;” rather, a relatively
small subset of individuals is responsible for the vast majority of violent crime. The ability
to prospectively identify those predisposed to commit violent criminal behavior would be of
great benefit in guiding decisions regarding bail, sentencing, probation/parole, court-ordered
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treatment, and civil commitment. At the level of policy, valid measures of individualized risk
for future violence would be immensely useful for targeting prevention and treatment-related
spending to maximize its benefit [3].

Author Manuscript

While behavioral prediction has a long - and somewhat fraught - history in the realm of law
and policy, recent advances in brain imaging have renewed interest in the potential to
accurately predict violent behavior. In particular, new insights into the neurobiological
architecture of violence and antisocial behavior [4–6] have generated substantial excitement
about the potential utility of neuroscientific methods for predicting future violent behavior
(what some have termed “neuroprediction”) [7,8]. The purpose of this paper is to critically
analyze the current state of neuroprediction in law, in order to guide future research and aid
policy-makers as they consider whether and how to apply such research. To that end, we will
first briefly summarize the history of behavioral and genetic prediction in law, and then
review the current state of neuroprediction efforts. We then review the challenges inherent in
any attempt to predict future behavior. We discuss several statistical and methodological
hurdles to valid predictive inference, which are general to any domain of prediction, and
outline best practices for future studies of neuroprediction.
Note that predictive models for binary outcomes (such as criminal recidivism) assess risks -i.e. probabilities within groups -- rather than forecasting individual outcomes. Nonetheless,
it is useful to administratively classify persons based on whether their group’s risk exceeds a
threshold. Policies based on such classification, even using mediocre models, can often
virtually guarantee aggregate gains, and thus that a plurality of those affected will benefit
from the policy.

Author Manuscript

Behavioral prediction of future violent behavior

Author Manuscript

Courts are tasked with both retrospective and prospective functions. Decisions about bail,
probation, and sentence length all reflect the fact that courts have a duty to prevent future
criminal acts in addition to determining guilt and assigning punishment for crimes that have
already been committed. Using behavioral risk factors to predict who will commit crime has
been an important component of American criminal law since the rise of probation and
parole in the late 19th-century, and a major concern of the mental health system since the
shift from “need for treatment” to “dangerousness” as the legal standard for civil
commitment in the 1970s [9]. A milestone in the scientific literature was the distinction
made by Meehl [10] between “clinical” prediction (in which predictions are based on a
clinician’s subjective judgments about a particular case) and “actuarial” (or statistical)
approaches to behavioral prediction (which rely upon statistical models to predict relevant
outcomes; see Box 1 for a detailed discussion of the general concept of “prediction”).
Across nearly every domain tested, actuarial approaches have been shown to outperform
clinical prediction, to such an extent that Meehl [11]stated that “There is no controversy in
social science which shows such a large body of qualitatively diverse studies coming out so
uniformly in the same direction as this one.” In the context of violent behavior, a
representative review of behavioral prediction [12] concluded that “one area in which the
statistical method is most clearly superior to the clinical approach is the prediction of
violence.” That is, in head-to-head contests between predictions that reflect the subjective
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judgments of human experts and predictions based on validated statistical models, the
statistical models have nearly always won.
Box 1
What does “prediction” mean?

Author Manuscript

The concept of “prediction” is fraught with misconception, in part due to the multiple
overlapping ways the term is used in scientific discourse. In common language,
prediction generally implies the anticipation of a future outcome based on information
available in the present. This is our primary meaning of the term in the present context, as
it would be in most legal contexts. Such predictions are made without knowledge of the
outcome, using information that temporally precedes that outcome. This usage is,
however, different from that often used in the context of statistical modeling, where the
term “predicted value” may be used to describe the output of a fitted regression model
obtained for some specific values of the model’s input variables. This latter usage is
indifferent to the relative timing of the input and outcome variables, and also to whether
the specific data point being used to generate the “prediction” was also used in fitting the
statistical model.

Author Manuscript
Author Manuscript

The fields of statistics and machine learning have developed sophisticated frameworks for
fitting models in ways that that allow quantification and optimization of the ability to
accurately predict outcomes for new samples, which we take to be the sine qua non of
“prediction”[73–76]. A fundamental motivation for more recent developments is an
appreciation of the pervasiveness of “overfitting”. Whenever a model is fit to a specific
dataset, the fitted parameters reflect both the signal in the data as well as the noise in that
dataset; this occurs even for simple models such as strictly linear regression on a single
predictor, but becomes increasingly problematic as the model becomes more complex.
An implication of this is that models will nearly always fit the dataset used to develop
them better than any other dataset [77], and thus that assessment of model goodness of fit
using the same data that were used to estimate the model parameters will almost
necessarily understate the model error when applied to new data. This phenomenon is
known as “shrinkage”[77].; Although there are methods for estimating and correcting for
shrinkage using standard parametric statistics, a more common approach arising from the
field of machine learning is to perform “cross-validation”, in which the model is
iteratively fit using subsets of a dataset (known as “training sets”) and then used to
predict the values of the held-out observations ( “test sets” or “validation sets”). These
approaches allow one to estimate the model’s performance on data that played no role in
the fitting of the model, which reduces the optimistic bias in predictive accuracy that
arises from overfitting when the same data are used to train and test the model. Although
cross-validation can provide valid estimates of out-of-sample generalization, it is not a
panacea, and can be easily misused in ways that can still inflate one’s estimates of
predictive accuracy [78].
In recent years, many behavioral instruments aimed at predicting crime have been published
that are not adequately characterized by a simple clinical-actuarial dichotomy. Rather, the
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behavioral risk assessment process now exists on a continuum of rule-based structure, with
completely unstructured (“clinical”) assessment occupying one pole of the continuum,
completely structured (“actuarial”) assessment occupying the other pole, and several forms
of partially-structured assessment lying in between [13]. While there is general agreement
that structured behavioral approaches are more predictively valid than unstructured ones,
how completely structured behavioral approaches compare with partially-structured
behavioral approaches (often termed “structured professional judgment”) is unresolved. One
meta-analysis of 28 studies found that the predictive validities of nine completely or
partially-structured prediction instruments were essentially “interchangeable” [14]. One
explanation for why different violence prediction instruments yield comparable accuracy is
that they measure shared risk dimensions. In a memorable demonstration of this point[15],
the items from several instruments were printed on paper strips, placed in a coffee can,
shaken, and randomly redistributed to create new prediction instruments. The “coffee can
instruments” predicted violent offenses as well as the originals from which the items came.

Author Manuscript

On the whole, this body of work shows that specific behavioral and trait dimensions can be
used to predict future violence with some degree of accuracy. However, even the best
predictive models are far from perfect [14]. Indeed, more recent meta-analytic work has
quantified the positive and negative predictive value of a range of risk assessment devices
[16], showing that these measures have a positive likelihood ratio (pLR: the ratio of the
likelihood of a positive prediction for those who do to those who don’t subsequently offend)
ranging from about 3.5 to 8. For comparison to medical diagnosis, the pLR for right lower
abdominal pain in appendicitis is 8.4 [17]. Moreover, despite its clear superiority to clinical
prediction, actuarial prediction has encountered significant pushback, with objections to socalled “moneyball sentencing” based on behavioral risk factors (e.g., employment,
education) made on constitutional, ethical, and theoretical grounds [9,18,19]. These
challenges, in concert with the explosion of interest in cognitive neuroscience over the last
decade, have led some to focus on the use of biologically-based variables as predictive
markers. A substantial body of previous work has examined the use of genetic prediction
(see Box 2), but here we focus on the use of direct measurements of brain activity through
neuroimaging. For a more general discussion of the use of neuroscientific and genetic
evidence in the courtroom, see [20]
Box 2
Lessons from the Genetics of Antisocial Behavior and Violence

Author Manuscript

Data from twin and family studies show that antisocial behavioral generally, and violence
specifically, is moderately heritable. Genetic factors appear to account for 40–60% of the
population-level variance in broad-band antisocial phenotypes[79], and heritability is
considerably higher (>80%) for subtypes encompassing both antisocial behavior and
callous-unemotional traits[80,81]. A number of risk-associated genetic variants have been
identified[82], but considerable attention has been focused on one specific polymorphism
in the MAOA gene (encoding the enzyme monoamine oxidase A). MAOA first came to
prominence in series of family-based studies of severely violent men, who were found to
possess a mutation that blocked production of this enzyme[83,84]. Complimentary work
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subsequently demonstrated that genetic deletion or hypoexpression of maoa markedly
increased impulsive and aggressive behavior in mice[85–87].
While mutations with effects as large as those described above are rare, a common
functional polymorphism exists in the MAOA gene that modulates expression of the
MAOA enzyme in the brain [88]. Significant associations with the low-expressing allele
(MAOA-L) of this variant have been reported in adult substance abusers[89–93],
adolescents with behavioral problems[83,84,94], and high levels of antisocial
traits[95,96][97]. These findings are largely consistent with a large body of work in
across species that links dysregulation in serotonin function during ontogeny to
impulsive-aggressive behavior[98].

Author Manuscript

The research cited above has led to the introduction of genetic testing for MAOA variants
in several recent murder cases in the U.S. and Europe, in which putative positive results
were introduced as mitigating evidence at sentencing, sometimes successfully. This is
concerning because numerous studies have failed to replicate the association between
MAOA variants and antisocial/violent behavior [99–105], in line with field-wide
concerns about the replicability of candidate gene approaches[106]. Moreover, even in
studies reporting significant associations the effect sizes tend to be small. A recent
paper[107] is notable for being an exception to this general rule, concluding that 5–10%
of all severe crime in Finland could be attributable to genetic variants in MAOA and
another gene (CDH13). However, their use of an extreme groups approach in a very small
sample suggests an overestimation of the true amount of variance explained by these two
common variants.

Author Manuscript

Given that effect sizes for individual genetic variants are so low, possessing a “risk” allele
provides little predictive information about whether a given individual is more or less
likely to commit violence. Roughly 40% of the population carries the low-expressing
MAOA allele (in individuals of European descent; allele frequencies vary by ancestry),
yet it is estimated that <0.01% of the U.S. population are arrested each year for violent
crime1. In other words, most people who possess the MAOA risk allele never go on to
commit acts of violence, suggesting that predictions of violence based on MAOA variant
status would likely lead to a very high rate of false positives. Similar conclusions can be
made for other previously proposed candidate genetic markers for criminal activity, such
as the 5-HTTLPR variant[98].

Enter: Neuroprediction
Author Manuscript

The advent of neuroimaging has marked a paradigm shift in understanding the biological
basis of human behavior. In the last quarter century, neuroscientists have witnessed the
explosive development of new tools for measuring brain function, structure, chemistry, and
connectivity. The promise of opening the black box of the human mind and wresting that
which is most personal - beliefs, motivations, intentions, and capacities- from our brains has
also generated substantial excitement amongst the general public. Each new neuroscientific

1https://ucr.fbi.gov/crime-in-the-u.s/2013/crime-in-the-u.s.-2013/tables/table-43
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advance is greeted with a chorus of speculation about its application to the real world, and
nowhere is the level of anticipation higher than in the courts, because law - more than almost
any other profession - faces daily the challenge of rendering judgements based on the
contents of that black box. Given lingering skepticism about actuarial prediction, the rapid
pace of discovery in neuroscience - coupled with the assumption among non-specialists that
biological variables are somehow more “real” than demographic or psychological ones - has
generated a great deal of enthusiasm for the use of brain imaging measures to predict
violence. Enthusiasm for neuroprediction is due, in part, to the presumed closer biological
proximity of brain-based measures to the causal processes that produce violent behavior,
which makes it reasonable to assume that measures of brain activity might support better
predictions. Indeed, neuroimaging techniques have great potential, but there are a number of
concerns about their application to complex real-world behaviors such as violence, which we
outline in the following sections.

Author Manuscript

Whether courts will be receptive to such biological risk factors is uncertain [21]; see Box 3
for a further discussion of the use of scientific data in legal decision making about individual
cases, known as the G2i (group to individual) problem. The United States Supreme Court
recently overturned a death penalty because an expert witness had testified that race was
“know[n] to predict future dangerousness.” The Court stated that the case “is a disturbing
departure from a basic premise of our criminal justice system: Our law punishes people for
what they do, not who they are” (Buck v. Davis, 137 S. Ct. 759, 2017). Whether
neuroscience markers will be considered attributes of “who a person is” in this sense is
unclear.
Box 3

Author Manuscript

Making individual predictions from group data: The G2I problem

Author Manuscript

The application of scientific research to legal settings raises a problem known as the
“group to individual” (G2i) problem [108–111], which has its roots in a key difference
between the goals of science and the legal system. Science is focused on characterizing
generalizable phenomena to establish mechanistic explanations that apply within
definable population groups and hence are generalizable to other members of those
populations (who may not yet have been observed). As a means to this end, most
scientific work aims to describe observations about groups of individuals and/or
collections of circumstances. By contrast, law is concerned with making concrete and
definitive determinations about particular individuals and circumstances [112]. Thus, in
science, individuals are generally incidental to the general insights they support, while in
law the individual is paramount: group or population-level scientific data are only
relevant to the extent that the data bolster or weaken the evidence provided in an
individual case. Unfortunately, however, observations about groups only rarely apply
universally to their individual members, such that group-level findings may provide only
very weak support for individual determinations. The G2i problem is relevant for any
scientific domain in which there is variability across individuals, including but not limited
to neuroscientific measures.
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Consider the following example. A neuroscientist uses fMRI to scan 100 participants
who are instructed to either lie or tell the truth about a set of facts. Contrasting brain
activity during lying with truth-telling reveals statistically significant activation in
dorsolateral prefrontal cortex (DLPFC). This permits the valid group-level inference that
lying is associated with DLPFC engagement. However, examination of each individual’s
data reveals that while most subjects exhibited higher DLPFC activity during lying, some
participants showed no difference and still others demonstrated lower DLPFC activity
during lying compared to truth-telling. In other words, “heightened DLPFC activity
accompanies lying” may be a valid group-level inference, but the application of this
inference to any one individual invites serious and profoundly consequential risk of both
false positives and false negatives [113]. Legal testimony in a hearing regarding
admissibility of fMRI lie detection in a federal Medicare fraud case provides an example
of the type of quandary that can arise. The scientist who was hired to administer fMRI lie
detection in support of the defendant’s innocence testified that the test was valid evidence
of the defendant’s general veracity, but refused to testify that the test confirmed the
truthfulness of his answer to any specific question at issue in the case. For this and other
reasons, the testimony was not admitted in evidence (US vs. Semrau, 07-10074 Ml/P). In
this case, the “individual” was a specific item rather than an individual person,
demonstrating the broad reach of the G2i problem.

The complex causal structure of real-world behavior

Author Manuscript
Author Manuscript

Whereas cognitive neuroscience has taught us a great deal about the neural bases of basic
cognitive, emotional, and social functions, we still know almost nothing about how trait-like
aspects of brain function, structure, chemistry or connectivity interact with social context
and other dynamic environmental factors to determine real-world behaviors such as
violence. What we can safely infer from recent work in other domains is that the causal
structure of these behaviors will be highly complex and multiply determined. With regard to
genetics, the last two decades of genome-wide association studies (GWAS) have shown that
any particular common genetic variant (e.g. those appearing in at least 1% of the population)
is unlikely to account for large effects on common phenotypes. For example, GWAS have
been used to identify replicable associations between common genetic variants and
behavioral phenotypes (such as educational attainment [22]) and mental illness (e.g.
schizophrenia [23]). However, each of these individual associations accounts for a
vanishingly small amount of variance in the phenotype (usually less than 1%); it is only
through the aggregation of large numbers of variants that one can start to account for the
heritability of these behaviors. The large effects estimated in earlier candidate-gene studies
were likely due to the combination of small samples (which are only powered to find large
effects) and publication bias[24].
On analogy to genetic data, it seems likely that any one measure of brain function, structure,
chemistry and connectivity will account for only a small amount of variance in violent
behavior. Further, while the neurobiological basis of inter-individual variability is coming
into increasing focus, we still know relatively little about how individual brains change over
time (intra-individual variability) [25]. Likewise, the relevance of lab-based measures of
Trends Cogn Sci. Author manuscript; available in PMC 2019 February 01.
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self-control (to take one relevant example) for predicting individual variability in real-world
behavior remains largely unclear. These latter two issues are especially germane to the
problem of violence prediction because violent behavior typically results from the
interaction of trait-like vulnerabilities in capacities related to self-control and emotion
regulation[6] with time-varying state factors (e.g. stress level and sleep deprivation) and
punctate eliciting events (e.g. provocation). It is difficult to reconcile the static nature of labbased assessments that might be used for prediction with the dynamic nature of real-world
violence. In addition, violence is a multidimensional construct, encompassing both reactive
subtypes (reflecting poor inhibitory control and emotion regulation) and goal-directed
subtypes (reflecting maladaptive action valuation)[26,27]. As these two facets of violence
likely reflect distinct neural mechanisms[27], it would seem unlikely that a single measure
(such as the commonly used go/no-go task) could assess risk for both. On balance, it would
seem safe to conjecture that accurate neuroprediction, if possible, will require aggregation of
neuroscientific data across multiple cognitive tasks and multiple measurement techniques.

Neuroprediction: Where do we stand?
Insights into the neurobiology of violence can be gleaned from an emerging body of brain
imaging work in clinical populations characterized by high levels of violent behavior,
especially people with psychopathy. Psychopathy is a particularly useful model for
understanding the neurobiology of violence because it encompasses both affectiveinterpersonal symptoms thought to underlie goal-directed violence and impulsive-antisocial
symptoms linked to reactive violence. In addition, it appears to be the psychological trait
most predictive of violent behavior[28]. It may thus serve as an effective intermediate
phenotype (or “endophenotype”[29]) for the study of violent behavior.

Author Manuscript
Author Manuscript

Structural and functional fMRI results converge to suggest that maladaptive behavior in
psychopathy - including violence - may arise from dysfunction within cortico-limbic and
cortico-striatal circuitry involved in affective arousal, emotion regulation, and value-based
decision-making. For instance, psychopathic individuals exhibit decreased amygdala and
vmPFC gray matter volume, as well as lower vmPFC cortical thickness [30,31]. Likewise,
psychopaths show reduced recruitment of amygdala and vmPFC during fear conditioning
and moral decision making [32–35], blunted amygdala responsiveness during affective
perspective-taking [36,37], and weaker vmPFC engagement in response to empathogenic
[38] and facial emotion stimuli [39]. Reduced functional and structural connectivity between
amygdala and vmPFC has also been reported in psychopathy [36]. There is some evidence
that the observed relationships between psychopathy, task-related brain activity and
ventromedial prefrontal cortex--amygdala connectivity are driven by the affectiveinterpersonal features of the disorder [35,39–42]. On the whole, this work is consistent with
the notion that the socio-emotional deficits of psychopaths may arise from cortico-limbic
circuit dysfunction [43,44].
While cortico-limbic dysfunction appears to play an especially prominent role in the
affective-interpersonal dimension of psychopathy, recent work highlights the importance of
cortico-striatal dysfunction for impulsive-antisocial symptoms in the disorder.
Amphetamine-induced dopamine release and reward anticipation-related activity within the
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nucleus accumbens (NAcc) have been shown to be elevated in individuals with high levels of
impulsive-antisocial traits[41,45–47]. Likewise, several groups have found evidence for
increased striatal gray matter volume in psychopathic offenders, particularly those with a
history of impulsive violence[48,49]. Notably, impulsive-antisocial behavior has also been
linked to prefrontal dysfunction during tasks of inhibitory control[27]. The combination of
diminished prefrontal activity and heightened striatal responsiveness has led some to suggest
that social norm transgressions, such as violence, could arise from impaired prefrontal
modulation of striatal value representations[6]. The studies above comprise a potentially
important empirical foundation for considering the neuroprediction of violence (but see [50]
for an important discussion of the differences between causation and prediction). It should
however be noted that most of these studies have not yet been replicated and, due to the
difficulties associated with enrolling criminal offenders, involved relatively small sample
sizes. Recent work by Kiehl and colleagues using mobile fMRI in comparatively large
samples of currently incarcerated offenders [51] represents a notable exception, and offers a
useful example of how present limitations in this area might be overcome (see Box 4 for
further discussion of this work).
Box 4
Neuroprediction of future criminal behavior

Author Manuscript

One study [51] has directly examined the predictive utility of neuroimaging data for
future criminal acts. Ninety-six adult offenders (incarcerated for either violent or
nonviolent crimes) were tested prior to release on a go/no-go task using fMRI, and the
relation between task-related activity in the anterior cingulate cortex (ACC) and felony
rearrests over up to four years (median 34.5 months) of follow-up was examined. The
estimated probabilities of rearrest for those with ACC responses below and above the
sample median were 60% and 46%, respectively. Rearrests for violent crimes were too
rare in the sample to support a separate analysis, so the study’s results have only limited
direct bearing on violence prediction, but the report raises questions that will similarly
apply to future studies of neuroprediction.

Author Manuscript

The study is an impressive logistic accomplishment. A mobile MRI scanning facility was
used on site at multiple correctional facilities, with well-established psychological testing
and fMRI image-acquisition protocols. Target and control ROIs were prespecified, with
seed coordinates chosen on the basis of peak BOLD activity in a comparably-sized nonoffender sample. While rearrest outcomes did not evidently influence data extraction or
statistical modeling choices, this paper and all others of similar nature would benefit from
inclusion of explicit statements that the analyses were blinded to outcomes of interest,
and formal pre-registration of the analysis plans.
A further analysis reported a survival model, but did not directly quantify prediction
accuracy. This was addressed in a follow-up paper [114] using a receiver operating
characteristic (ROC) analysis [115]. This paper also used bootstrap resampling to
estimate and correct for shrinkage (overoptimism bias), which reduced estimated ROC
areas from 68% and 76% (for all arrests and nonviolent arrests respectively) to the more
conservative values of 63% and 69%, values described as “modest.” There are, however,
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two limitations. The bootstrap correction of overoptimism bias relies primarily on insample prediction, and thus on average tends to somewhat undercorrect for bias
(compared to crossvalidation methods). More importantly, the approach was applied only
to the full model, and thus does not provide overoptimism-corrected estimates relevant to
the primary question of interest, which is the incremental contributions of ACC to
predictive accuracy.. Repeated crossvalidation of the incremental ACC contributions to
predictive accuracy would thus have increased the utility of this report. More generally,
inclusion of overoptimism bias-corrected estimates of the incremental contributions of
neuroimaging or other neuroscience-based markers would be similarly important in
future reports of this nature.

Author Manuscript

Finally, wide scientific acceptance of any neuroimaging predictor of violence will require
true validation by a combination of replications across a set of separate cohorts varying
widely in sociodemographic, psychopathological, and criminological characteristics.

Author Manuscript

Finally, the body of work highlighted above does not speak to underlying brain circuit
dysfunction underlying violence per se. Rather, these studies focus largely on psychopathy,
which is certainly associated with violence but not to the degree that it could be considered a
proxy. As one example, while amygdala dysfunction in psychopathy has been replicated by
multiple groups, we know of no work to date that examines the specificity of amygdala
dysfunction for violent behavior. Without such work, it is impossible to know whether
amygdala dysfunction in psychopathy is responsible for the higher rates of violence in
psychopathic individuals, versus - as one example - their need for stimulation or boredom
proneness. Research in this area would be considerably advanced by a stronger focus
symptom specificity, with the goal of mapping brain circuit dysfunction to specific sets of
behaviors (e.g. violence and aggression) rather than categorical disorders[52].

Author Manuscript

The well-established association between psychopathy and violent behavior, in concert with
our advancing understanding of the neurobiology of psychopathy, hint that it might be
possible to predict future criminal behavior from neuroimaging data. However well
motivated such an endeavor may be, we note that any particular neuroimaging signature of
psychopathy need not, in principle, predict violence any better – or even as well as – related
clinical or behavioral measures. Thus, studies must address several open questions before
such candidate neuroimaging signatures for violent behavior can be seriously entertained
(see Outstanding Questions). There have been remarkably few studies that have directly
examined the relationship between neuroscientific variables and violence. One remarkable
example is discussed in detail in Box 4, where we examine the application of the foregoing
principles to the landmark study by Aharoni and colleagues [51].
Outstanding Questions Box
•

Is the protocol for eliciting the signature from a future individual explicit
enough and robust enough for effective replication in a range of other
settings?

•

Were the components of the protocol for each subject (regions of interest,
masks, normalizations, measures of hemodynamic response and BOLD
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contrast) completely uninfluenced by, and preferably blinded to, that subject’s
criminal behavior outcomes?

Author Manuscript
Author Manuscript

•

Are the statistical measures used to report prediction benefit supported by
methodological studies in the prediction analysis literature, and are these
measures reported with error ranges accounting for measurement and
sampling variability?

•

Do reported measures of predictive benefit include measures of incremental
predictive value, relative to prediction from other non-neuroimaging measures
(which are likely to be less onerous and/or expensive to ascertain)?

•

Were these measures and their error ranges obtained from a) direct estimation
from the entire derivation sample, b) bootstrap validation or c) crossvalidation from the derivation sample, d) from a test sample withheld from the
model-fitting process, and/or e) from one or more entirely external validation
samples?

•

Does the sample have appropriate demographic representation and does it
access the full distribution of relevant behaviors? For example, if an
incarcerated population is used, does it sample the full distribution of criminal
phenotypes (e.g. never violent, occasionally violent, frequently violent?). If
stratified sampling is used, is the variable employed for stratifying
psychometrically valid and amenable to independent corroboration (e.g. by
department of correction records, charging documents, etc.)? If a nonincarcerated comparison group is used for inference, is this group matched
along relevant demographics (e.g. substance use, SES, race, education,
reading ability)?

Neuroprediction in other domains

Author Manuscript

Beyond the realm of violence, there are several examples of studies that have effectively
used neuroimaging for prediction of behavioral outcomes, an area reviewed recently [53].
One particular domain that has seen recent success is the prediction of treatment outcomes
in psychiatric disorders. While many studies have examined associations between
neuroimaging signals and treatment outcomes, only recently have appropriate predictive
modeling tools been applied to properly assess predictive validity. One study [54] examined
the relation between brain responses to angry versus neutral faces and response to cognitivebehavioral therapy in individuals with social anxiety disorder. A model including both brain
responses as well as variables reflecting drug treatment group and disease severity was able
to account for 41% of the variance in symptom change, versus 12% for a model that only
included the severity and drug variables. In another example, [55] investigators examined
whether the interaction between early life stress and amygdala response to fearful or happy
faces could be used to predict the response to antidepressant medications in depressed
individuals. Using cross validation, they showed that the prediction model using these
variables was substantially better than one that did not include fMRI variables; the crossvalidated sensitivity of the best model was 0.84, and the specificity was 0.69, suggesting that
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the technique could potentially provide useful information to physicians. Each of these
studies was relatively small and will thus require further replication and validation, but they
suggest that there is potential for neuroimaging in the prediction of behavioral outcomes and
treatment response. We would also propose that the principles and best practices raised in
the present paper would be useful as guideposts for neuroprediction regardless of the
specific domain of prediction, and thus could be useful in assessing these studies of
psychiatric neuroprediction as well.

Challenges for neuroprediction
There are a number of potential challenges that will make the practical application of
neuroprediction difficult, particularly with regard to the prediction of future violent acts.

Author Manuscript

Foremost are the selection effects that are likely to occur due to the specific requirements of
the imaging process. Participation in an fMRI study requires a relatively compliant
individual who is willing to enter the scanner and behave as instructed. Thus, oppositional or
defiant individuals are unlikely to be successfully imaged, and individuals with a chaotic
lifestyle are likely to have trouble keeping their appointment for imaging. Even for
compliant individuals, there are selection effects that may occur in relation to impulsivity.
Highly impulsive individuals are less able to remain still in an MRI scanner for long periods
of time [56], such that even if they are successfully imaged, their data may be corrupted or
have lower signal-to-noise in comparison to non-impulsive individuals. In practice, it may be
very difficult to disentangle reduced task activation from increased noise due to head
motion.

Author Manuscript

A second challenge comes from the potential for intentional countermeasures. Once
predictive models are developed, it is likely that strategies could be developed to help
individuals appear less dangerous. Some obvious strategies include intentional head
movement or breath holding, both of which would induce signal changes substantially larger
than the small (1–5%) changes induced by task activation. More subtle evasive strategies
could rely upon cognitive subversion. For example, a subject in the go/no-go task might be
coached to try to withhold his or her responses on go trials; such subterfuge could
potentially be detected (e.g. through analysis of the behavioral data) but nonetheless would
leave neuroprediction methods open to questions of reliability and sensitivity, and detecting
these countermeasures is likely to be more difficult than detecting countermeasures on
psychological tests. Recent work in lie detection [57] and memory detection [58] has shown
that such cognitive countermeasures can substantially reduce the accuracy of fMRI
classification of mental states.

Author Manuscript

A third challenge relates to the degree to which observed neuroscientific predictors may be
confounded with other variables that are actually supporting predictive validity. An
outstanding example of this was seen in the ADHD-200 competition to generate diagnostic
classifiers for attention deficit/hyperactivity disorder based on neuroimaging data[59]. An
initial neuroimaging dataset with 776 individuals (491 healthy controls and 285 individuals
diagnosed with ADHD) was released for use in model development; later, an unlabeled test
dataset comprising 197 individuals was released, and competitors were asked to submit their
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predictions for each individual (ADHD vs. control, and further diagnosis of ADHD
subtypes). Many of the competitors were able to generate predictive models with abovechance accuracy on the basis of the neuroimaging data, but the best performing model did
not actually use the imaging data at all --- it simply used the demographic data (age, sex,
handedness, and IQ), which allowed accurate prediction of ADHD status because of sex and
IQ differences between the subject groups[60]. Without large enough samples to pull out
such potential confounds, the interpretation of neuroimaging results in terms of mechanism
will be very challenging.

Author Manuscript
Author Manuscript

A final challenge comes in assessing the generalizability of reported predictive accuracy to
new samples. There is increasing concern about the degree to which results reported in the
literature may overestimate the true sizes of reported effects [24]. In comparison to
behavioral models, neuroimaging data have much higher dimensionality and much greater
analytic flexibility [cf. 61], and it is known that this flexibility can grossly inflate Type I
error rates [62,63]. There is also growing concern that the use of machine learning methods
with small samples can result in highly inflated predictive accuracies[64]). Without an
explicit a priori analysis plan, it is not possible to assess the degree to which any particular
result may reflect data-driven analysis choices (either intentional or unintentional). One
solution to this problem is to encourage replication of any particular result, as is common in
genetic association studies [65] and is an emerging practice in psychology. However, for
very precious samples such as the one collected by Aharoni et al. [51], this may not be
practical. A useful alternative in such a situation would be pre-study registration for any
research study that is meant to influence public policy, similar to the approach currently used
for clinical trials. While not a cure-all, a greater emphasis on external validity and reporting
of out-of-sample prediction measures would help to improve robustness of published study
results.

Best practices for neuroprediction
It is certain that future research will continue to assess the ability of neuroscience methods to
predict violent behavior, and we hope that such research will ultimately prove to be
effective, given the pressing need for more effective prediction of future violence. Here we
outline a set of principles that will help maximize the effectiveness and robustness of future
studies. We would also note that most of these principles are not unique to neuroprediction,
but, in principle, should apply to any new predictive method.
Pre-registration

Author Manuscript

The credibility of clinical trials in medicine has been greatly enhanced by the requirement
for registration of study designs, hypotheses, and outcome measures prior to undertaking a
study. In particular, the natural experiment occasioned by increased requirements for clinical
trial registration in 2000 has shown that positive outcomes are more likely and estimated
treatment effects are significantly larger for unregistered than for registered studies [66,67].
This is particularly important for fMRI given the immense degree of analytic flexibility in
fMRI analysis [68]. There is a growing consensus (shared by most of the present authors)
that pre-study registration of designs, hypotheses, analysis plans, and outcome measures
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could greatly increase both the reliability and acceptance of results from neuroimaging
studies.
Validation

Author Manuscript

It is essential that all predictive outcomes be validated using an independent sample. The
incorporation of repeated cross-validation and/or bootstrap validation in the process of
model selection, and in reporting of model performance using a discovery cohort, can
certainly reduce overoptimism bias and naïve applications based on early results (see Box
1). But while these methods can be useful for assessing the best model for a particular
dataset, they also can be biased by preprocessing and multiple, iterative model
reassessments. The gold standard should be a completely separate validation dataset that is
kept aside until final testing of the hypotheses, using the models developed from the training
dataset. Another alternative is for different research groups to separately test a specific
hypothesis in independent studies, which are then reported in a single manuscript. This
proposal is inspired by the now-standard requirement for replication in genetic association
studies[69], which has motivated consortia to collaborate on papers that include replication
across multiple samples. Yet another provocative alternative is the use of “blind analysis”
[70], in which the researcher analyzing the data is blinded to some aspect of the data (e.g.
through shuffling of variable labels).

Author Manuscript

It is also essential that neuropredictive methods are compared against the state of the art in
behavioral prediction methods. It is common in neuroimaging studies to find that the
predictive accuracy of imaging data is well above chance, but that the marginal improvement
of prediction for neuroimaging compared to behavioral prediction is miniscule. Given the
substantial added expense of neuroimaging compared to actuarial prediction, it is important
to establish that neuropredictive methods improve prediction sufficiently to overcome the
relative cost. This is, of course, the same issue as commonly occurs in medical science,
where disease biomarkers considered promising when studied in isolation are then found to
be redundant with less expensive predictors in routine workups. One counterpoint to this
maxim is when neuroimaging provides greater mechanistic insights into the nature of
prediction; for example, it could be the case that neuroimaging and behavioral measures are
equally predictive of behavior, but the neuroimaging data provide additional guidance
regarding the most effective therapeutic means for preventing further violence in each
individual.
Appropriate norms

Author Manuscript

The development of norms for actuarial methods of violence prediction has required very
large sample sizes in order to ensure that the predictions are accurate across a wide range of
demographics. For example, recent studies that have validated the Oxford Risk of
Recidivism tool (OxRec) [71] and the Oxford Mental Illness and Violence tool (OxMIV)
[72] had samples sizes of 47,326 and 75,158 respectively. For neuroimaging prediction to be
equally reliable, we will need norming datasets large enough to provide accurate predictions
for individuals who vary in many different ways. Without such norms, the criteria for
prediction will vary due to differences in the sociodemographic and clinical compositions of
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the samples from which they are derived, potentially increasing controversy in the
interpretation and acceptance of individual risk assessments.

Concluding Remarks

Author Manuscript

The development of accurate methods to predict future violent behavior using behavioral,
genetic, and/or neuroscientific data could have a significant impact on the legal system,
especially on sentencing as well as prevention and treatment. Deeper and more mechanistic
understanding of violent behavior—with objective techniques—has the potential to reduce
suffering of victims, decrease the enormous economic burdens of crime, and minimize
foregone futures of young people whose life trajectories could have been altered but for their
involvement in impulsive crimes. Neuroprediction offers the potential to identify causal
mechanisms that distinguish the callous psychopath from the neurologically immature or
dysfunctional individual who might benefit from treatment or preventive measures. Despite
the potential, however, current techniques fall far short of this ideal of objective mechanistic
prediction. As we have discussed, the limited studies that have been published do not seem
to approach what would be required to make definitive judgments in a legal context, or even
to meet the legal standards for admissibility of expert testimony (see Outstanding
Questions). As research accumulates, the uncertainty regarding accuracy of individual
predictions may diminish, but the societal impact of research on neuroprediction will depend
on future commitments to the application of rigorous methodology. Whether neuroprediction
will ever reach its hypothetical potential, transcending the role of circumstances in human
behavior to warrant serious impact in legal settings, remains an open question.
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Trends Box
•

Violent behavior is a costly large-scale societal problem

•

There is growing interest in using neuroscience data to assess risk for future
violent behavior, but the utility of neuroscience for violence risk assessment
remains to be established

•

We review what is currently known about the underlying neurobiological
mechanisms of violence, and evaluate recent neuroprediction efforts.

•

Finally, we outline a set of practices for enhancing the validity and reliability
of future risk assessment based on neuroscientific measures.
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